1996 – 2003 (7 years)BUENOS AIRESHuman-resource development. Generation and setting up of original protocols for different tissue engineering products. Advice and supervision in the construction of a state-of-the-art BSL3 facility. Production of keratinocyte´s suspension and layers, dermoepidermic devices, chondrocytes in suspension, cornea epithelium, cavernous tissue, myoblasts, and genetically modifies tissues.

follow us

address

I understand that regardless of my financial standing I can view the investment opportunities offered on the Cal Stock Exchange website. However, to be eligible to invest in a company offered through Cal Stock Exchange I must be at minimum an accredited investor as defined in Rule 501 of Regulation D of the Securities Act of 1933*.
*Rule 501 of Regulation D defines an Accredited Investor here